1. Chronic Hepatitis C Therapy: Changing the Rules of Duration
Brian L. Pearlman 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 8, Pages (August 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Terms and Conditions

2. Figure 1
Alternative treatment algorithm for chronic hepatitis C patients infected with genotype 2 or 3 viruses. Not recommended for patients with advanced fibrosis or for those with genotype 3 infection and high viral load. aAlternatively, use 1000–1200 mg ribavirin daily; busing qualitative or sensitive quantitative RNA assay; cconsider extending treatment duration.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions

3. Figure 2
Alternative treatment algorithm for chronic hepatitis C patients infected with genotype 1 virus and low viral load (<800,000 IU/mL). Not recommended for patients with advanced fibrosis. aAlternatively, use 1000–1200 mg ribavirin daily; busing qualitative or sensitive RNA assay; cif 12-week EVR achieved but RNA still detected, consider checking 24-week RNA; if positive, stop treatment.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Terms and Conditions